|
|
||||||||||||||
|
|
|
||||||||||||||
| Home | Text Version | Site Index | NIH Public Access | Off-Site Access Text Size: A > A > A | ||||||||
|
menu bar | |||||||
|
Selective Bibliography of
Dr. Robert
S. Kerbel "Amplifying Standard or Metronomic Chemotherapy Efficacy Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib BRITISH JOURNAL OF CANCER 98 (10):1619-1629 May 20 2008 2. Kerbel RS Molecular origins of cancer: Tumor angiogenesis NEW ENGLAND JOURNAL OF MEDICINE 358 (19):2039-2049 May 8 2008 3. Voskas D, Babichev Y, Ling LS, Alami J, Shaked Y, Kerbel RS, Ciruna B, Dumont DJ An eosinophil immune response characterizes the inflammatory skin disease observed in Tie-2 transgenic mice JOURNAL OF LEUKOCYTE BIOLOGY May 1 2008 4. Kuwai T, Nakamura T, Sasaki T, Kim SJ, Fan D, Villares GJ, Zigler M, Wang H, Bar-Eli M, Kerbel RS, Fidler IJ Phosphorylated epidermal growth factor receptor on tumor-associated endothelial cells is a primary target for therapy with tyrosine kinase inhibitors NEOPLASIA 10 (5):489-500 May 2008 5. Allegrini G, Falcone A, Fioravanti A, Barletta MT, Orlandi P, Loupakis F, Cerri E, Masi G, Di PA, Kerbel RS, Danesi R, Del TM, Bocci G A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients BRITISH JOURNAL OF CANCER 98 (8):1312-1319 Apr 22 2008 6. Donate F, Parry GC, Shaked Y, Hensley H, Guan X, Beck I, Tel-Tsur Z, Plunkett ML, Manuia M, Shaw DE, Kerbel RS, Mazar AP Pharmacology of the novel antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2): observation of a U-shaped dose-response curve in several preclinical models of angiogenesis and tumor growth CLINICAL CANCER RESEARCH 14 (7):2137-2144 Apr 1 2008 7. Bender JL, Adamson PC, Reid JM, Xu L, Baruchel S, Shaked Y, Kerbel RS, Cooney-Qualter EM, Stempak D, Chen HX, Nelson MD, Krailo MD, Ingle AM, Blaney SM, Kandel JJ, Yamashiro DJ Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group Study JOURNAL OF CLINICAL ONCOLOGY 26 (3):399-405 Jan 20 2008 8. Ebos JM, Lee CR, Bogdanovic E, Alami J, Van SP, Francia G, Xu P, Mutsaers AJ, Dumont DJ, Kerbel RS Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth CANCER RESEARCH 68 (2):521-529 Jan 15 2008 9. Ciarrocchi A, Jankovic V, Shaked Y, Nolan DJ, Mittal V, Kerbel RS, Nimer SD, Benezra R Id1 restrains p21 expression to control endothelial progenitor cell formation PLOS ONE 2 (12):e1338 Dec 19 2007 10. Man S, Munoz R, Kerbel RS On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing CANCER AND METASTASIS REVIEWS 26 (3-4):737-747 Dec 2007 Created 6/3/08
|
| Home - NCI-Frederick - CCR - PhoneBook - Disclaimers - Accessibility - Privacy | ||||
|
 |
© 2002-2008 NCI-Frederick Scientific Library,
Wilson Information Services
Corporation P.O. Box B., Bldg. 549, Frederick, MD 21702 Tel: (301) 846-1093 Email: NCIFredLibrary@mail.nih.gov Last Updated: Monday, September 22, 2008 Suggestion Box |
 |
 |
Contact Us
My Account / Renew Items